Postoperative Re-irradiaTion With and Without HYPERthermia: Toxicity, Quality of Life and Survival in Patients With Locoregional Recurrent Breast Cancer

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 31, 2027

Study Completion Date

May 31, 2027

Conditions
Locoregional RecurrenceBreast CancerRe-irradiationHyperthermia
Interventions
OTHER

No interventions, patient-reported outcomes (PROMs) and toxicity will be collected in both groups.

Patients will receive standard of care. Patients need to fill in questionnaires, these are additional interventions for the included subject. Questionnaires for patient-reported outcomes (PROMs) and toxicity will be filled in one week before treatment, one week before re-irradiation, one week and three months after re-irradiation, one, two and five years after surgery.

Trial Locations (1)

Unknown

RECRUITING

Amsterdam UMC, Amsterdam

All Listed Sponsors
collaborator

Borstkanker Onderzoek Groep

NETWORK

collaborator

Comprehensive Cancer Centre The Netherlands

OTHER

collaborator

Dutch Cancer Society

OTHER

lead

Amsterdam UMC, location VUmc

OTHER